Towards extracellular vesicle based gene therapy for Huntington's disease
<p>Huntington's disease (HD) can be regarded as a model neurodegenerative disorder to screen potential genetic based therapeutics and their carriers. It is an autosomal dominant disorder caused by a mutation in a single gene that leads to progressive neurodegeneration caused in part by pr...
Autor principal: | O'Loughlin, A |
---|---|
Altres autors: | Wood, M |
Format: | Thesis |
Publicat: |
2016
|
Matèries: |
Ítems similars
-
Real-time three-dimensional tracking of single vesicles reveals abnormal motion and pools of synaptic vesicles in neurons of Huntington's disease mice
per: Sidong Chen, et al.
Publicat: (2021-10-01) -
DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
per: Bhagyashree S. Joshi, et al.
Publicat: (2021-11-01) -
The Dichotomous Role of Extracellular Vesicles in the Central Nervous System
per: David R. Graykowski, et al.
Publicat: (2020-09-01) -
Presymptomatic targeted circuit manipulation for ameliorating Huntington’s disease pathogenesis
per: Ebenezer C. Ikefuama, et al.
Publicat: (2025-03-01) -
Neuronal-enriched small extracellular vesicles trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
per: Zhichun Chen, et al.
Publicat: (2024-07-01)